國家衛生研究院 NHRI:Item 3990099045/9190
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857817      線上人數 : 835
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/9190


    題名: Ground glass hepatocytes coexpressing hepatitis B virus X protein and surface antigens effect on oncogenic effects and tumorigenesis
    作者: Su, IJ;Wu, HC;Tsai, HW;Teng, CF;Hsieh, WC;Lin, YJ;Wang, LHC;Yuan, Q
    貢獻者: Division of Infectious Diseases
    摘要: Background: Hepatitis B virus (HBV) X protein (HBx) and pre-S2 deletion mutant large surface antigens have been recognized as oncoproteins that induce hepatocellular carcinoma (HCC). The interaction of these two oncoproteins in the hepatocytes and its significance in tumorigenesis remains to be elucidated. Methods: In this study, a newly developed monoclonal antibody designed specifically against HBx was used for immunohistochemical and double-labeled immunofluorescence studies and the expression of HBx and surface antigens were evaluated. In vitro studies and transgenic mice models were used to evaluate the interaction and oncogenic effects of these two viral oncoproteins. Results: We observed the co-expression of HBx with surface antigens in ground glass hepatocytes in 5 of 20 hepatitis B surface antigen positive livers. In vitro, hepatocytes co-expressing HBx and pre-S2 mutant showed an enhanced expression of vascular endothelial growth factor-A (VEGF-A), phosphorylated Akt1/2/3 (p-Akt1/2/3), phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) and phosphorylated mammalian target of rapamycin (p-mTOR) signals. Transgenic mice harboring the double HBx and pre-S2 mutant construct plasmids developed HCCs at an average of 15.1 months, earlier than that of HBx (16.9 months) or pre-S2 mutant (24.5 months) alone. Interestingly, the oncogenic signals of VEGF-A, p-Akt1/2/3, p-ERK1/2, and p-mTOR were sequentially and differentially activated at different stages in the progression of tumorigenesis. Phosphorylated mTOR was consistently activated in transgenic and human HCCs. Conclusions: We conclude that ground glass hepatocytes co-expressing HBx and surface antigens may exhibit enhanced oncogenic effects and tumorigenesis in chronic HBV infections. The mTOR signal cascade may represent the key regulator in HBV tumorigenesis and is implicated for the design of HCC therapy.
    日期: 2014-05
    關聯: Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e15115.
    Link to: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/e15115
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0732-183X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000358613200516
    顯示於類別:[蘇益仁(2002-2015)] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000358613200516.pdf52KbAdobe PDF482檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋